Mycio Wealth Partners, LLC Amgen Inc Transaction History

Mycio Wealth Partners, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 14, 2020	SELL	$182.24 - $241.7 $682,306 - $904,924	-3,744 Closed	0 $0
Q4 2019 Feb 13, 2020	SELL	$189.21 - $243.2 $155,530 - $199,910	-822 Reduced 18.0%	3,744 $903,000
Q3 2019 Nov 12, 2019	BUY	$174.11 - $208.62 $38,652 - $46,313	222 Added 5.11%	4,566 $884,000
Q2 2019 Aug 05, 2019	BUY	$166.7 - $195.41 $48,176 - $56,473	289 Added 7.13%	4,344 $801,000
Q1 2019 Apr 18, 2019	BUY	$180.87 - $203.88 $1,627 - $1,834	9 Added 0.22%	4,055 $770,000
Q3 2018 Oct 25, 2018	SELL	$185.29 - $208.89 $61,701 - $69,560	-333 Reduced 7.6%	4,046 $839,000
Q2 2018 Jul 19, 2018	SELL	$166.05 - $186.51 $16,937 - $19,024	-102 Reduced 2.28%	4,379 $808,000
Q1 2018 Apr 27, 2018	SELL	$169.43 - $198.0 $4,744 - $5,544	-28 Reduced 0.62%	4,481 $764,000
Q4 2017 Jan 31, 2018	SELL	$168.79 - $188.59 $4,726 - $5,280	-28 Reduced 0.62%	4,509 $784,000
Q3 2017 Oct 19, 2017	SELL	$167.29 - $191.0 $86,154 - $98,365	-515 Reduced 10.19%	4,537 $846,000
Q2 2017 Aug 10, 2017	SELL	N/A	-542 Reduced 9.69%	5,052 $870,000
Q2 2017 Aug 08, 2017	BUY	N/A	5,594	5,594 $918,000

3,122

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $149B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Mycio Wealth Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Mycio Wealth Partners, LLC with notifications on news.